Seamless transparent pharmacovigilance solutions
Thorough collection and assessment of product safety information is essential to the success of both clinical research studies and in maintaining post-marketing product licenses. Our team of over 300 global Pharmacovigilance staff members will bring together all safety services into a seamless delivery solution that focuses on transparency, easy to review outputs, and with a strong focus on continuous quality improvement and operational efficiency.
- Drug Safety Reporting Solution
- Affiliate Level Solution
- Low-cost high-quality case processing model
- Assigned functional lead for clear communication routes and accountability
- Robust regulatory intelligence for over 80 countries
- Global reach and 24/7 coverage for Clinical Trials, Post-Marketing and Medical Device submissions
- Over 99% compliance with regulatory reporting timelines
Drug Safety Reporting Solution
Our solution ensures compliance through automation. Based on an innovative cloud-based system and featuring automated and configurable business rules, it enables you to gain visibility into the safety profile of an investigational product throughout its lifecycle.Read more
Outsourced Affiliate Level Solution
This whitepaper explores the benefits in adopting an outsourced model for pharmacovigilance that is centrally managed and geographically dispersed, ensuring efficient and compliant delivery whilst retaining the effectiveness of a local presence.Read More
Support in a changing regulatory environment
Our multilingual team of experts in Europe, Asia, Latin America and North America, have a proven track record of handling regulatory reporting. We have above industry standard retention rates, providing you with stable project teams and consistency in end to end safety reporting. Our dedicated IT team provides 24 hour support our software solutions enabling an around the clock service.
We can provide services to support Competent Authority, Ethics Committee, Investigator and Business Partner submissions, Post-marketing and Medical Devices. We are experienced with various types of submissions, including country specific on-line portals.
Our procedures ensure high quality and compliance in our reporting and a proven track record of submission to all countries. A dedicated Safety Reporting Quality Assurance team, will help you to maintain excellent inspection outcomes, with support from a stable Management team to provide oversight and governance.
In an ever changing environment you need to be well informed of how regulatory changes may impact your product strategy to assure compliance. We have a cross-functional Regulatory Change Management team which drives readiness for:
- Amendments to Regulation (EC) No 726/2004
- Directive 2001/83/EC
- Commission Implementing Regulation (EU) No 520/2012
- Updated GVP Module VI, IX
- ISO ICH E2B(R3)
- ISO IDMP
- EU Clinical Trial Regulation No 536/2014
ICON Pharmacovigilance experience
300+Pharmacovigilance staff members
99%Compliance with regulatory reporting timelines
A key factor in delivering successful projects is robust project documentation, managed by well trained project personnel. At ICON we maintain an extensive library of SOP and procedures governing our case handling and processing to ensure staff training and quality.
In addition each client is assigned a functional lead who coordinates activities and ensures the quality of outputs that meet clients' defined Key Performance Indicators (KPIs).
Case processing capabilities include receipt, data entry, narrative writing, coding, quality control, medical review, query management, and safety submissions. Over the last 3 years we’ve processed an average of over 30,000 reports/year.
ARGUS safety database
Using the Oracle ARGUS safety database, we configure a dedicated schema for each client. The system is FDA regulation 21 CFR Part 11 compliant and has the capacity for generation of all standard regulatory and periodic reports.
We can also support database migrations, having rescued ongoing studies from other CROs, as well as having transferred legacy database of over 5,000 cases.
Safety reporting intelligence
Keeping up to date with regulatory changes worldwide can be a challenge. Our dedicated team translates complex local and international legal regulatory requirements to a clear, compliant submission decision. We review legal documents from around the world, and are in direct daily contact with international regulatory bodies.
The regulatory updates are maintained in an online system for real time access. This includes Competent Authority, Ethics Committee and Investigator safety set-up and expedited and periodic submission decisions for Clinical Trials, Post-Marketing, Medical Devices, In Vitro Diagnostics, along with scope for other areas. You can also avail of our Help Desk service for regulatory safety reporting queries.
If you are bringing your product into the EEA market, we can provide specialist technical expertise to advise you. Our trainers are trained directly with the EMA to cover EMA registrations, EudraVigilance submissions, and XEVMPD. Our experts participate in EMA organised training and development programs on a regular basis to ensure they are up to date with the latest regulatory conditions.
Affiliate management from many to one
To significantly minimise the complications and cost of managing numerous affiliates around the globe, we offer smooth transition of affiliate PV processes to ICON which will allows you to deal with one vendor, receive one report, have one primary point of contact, wihich also limits the number of vendors to audit.
We have a proven record in delivering projects within the affiliate model across Asia, Pacific, Europe, North and South America, Middle East and Africa along with over 99% compliance in ICSRs submissions.
Global and local literature monitoring
ICON also has significant experience in literature search services, having performed this specialised service for the last 8 years using Pubmed and/or Embase. We can provide both routine weekly monitoring and also for periodic report generation and signal management.
Our expert literature team performs local literature surveillance in accordance with local legislation and review search results from the Medical Literature Monitoring (MLM) performed by EMA.